Capital Research Global Investors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-144,486	Closed	-$17.3M	–	462
2017 Q4	$17.3M	Buy	144,486 +423	+0.3%	+$51.5K	0.01%	386
2017 Q3	$20.2M	Buy	144,063 +1,868	+1%	+$254K	0.01%	381
2017 Q2	$17.3M	Buy	142,195 +970	+0.7%	+$113K	0.01%	386
2017 Q1	$17.1M	Sell	141,225 -7,149,175	-98%	-$922M	0.01%	387
2016 Q4	$892M	Sell	7,290,400 -8,014,731	-52%	-$981M	0.29%	91
2016 Q3	$1.88B	Sell	15,305,131 -10,284,191	-40%	-$1.32B	0.62%	43
2016 Q2	$2.99B	Sell	25,589,322 -2,012,885	-7%	-$286M	1.02%	22
2016 Q1	$3.84B	Hold	27,602,207	–	–	1.32%	12
2015 Q4	$5.27B	Buy	27,602,207 +194,323	+0.7%	+$33.9M	1.8%	8
2015 Q3	$4.29B	Buy	27,407,884 +1,074,143	+4%	+$196M	1.53%	10
2015 Q2	$4.76B	Buy	26,333,741 +1,570,549	+6%	+$271M	1.56%	11
2015 Q1	$4.29B	Buy	24,763,192 +473,092	+2%	+$85.6M	1.47%	10
2014 Q4	$4.49B	Buy	24,290,100 +49,800	+0.2%	+$9.23M	1.53%	11
2014 Q3	$4.02B	Buy	24,240,300 +10,235	+0%	+$1.68M	1.39%	12
2014 Q2	$3.79B	Buy	24,230,065 +745,592	+3%	+$118M	1.32%	13
2014 Q1	$3.57B	Sell	23,484,473 -218,639	-0.9%	-$34.8M	1.29%	12
2013 Q4	$3.15B	Buy	23,703,112 +1,498,586	+7%	+$180M	1.17%	13
2013 Q3	$2.58B	Buy	22,204,526 +776,426	+4%	+$85.2M	1.02%	19
2013 Q2	$1.98B	Buy	+21,428,100	New	+$2.06B	0.84%	25